martes, 6 de enero de 2026
Lymphoma in the BiTE era The Lancet Haematology +++ +...
Lymphoma in the BiTE era
The Lancet Haematology
https://www.thelancet.com/journals/lanhae/article/PIIS2352-3026(25)00344-8/fulltext?dgcid=raven_jbs_etoc_email
Intravenous iron for non-anaemic iron deficiency in pregnancy: a multicentre, two-arm, randomised controlled trial
Tayyiba Wasim, FRCOGa ∙ Natasha Bushra, MRCOGa ∙ Tahira Nasrin, FCPSa ∙ Shamsa Humayun, FCPSb ∙ Arif Tajammul, FRCOGc ∙ Khadija Irfan Khawaja, FCPSa ∙ et al
https://www.thelancet.com/journals/lanhae/article/PIIS2352-3026(25)00315-1/abstract?dgcid=raven_jbs_etoc_feature_lanhae
Iberdomide plus low-dose cyclophosphamide and dexamethasone in patients with relapsed and refractory multiple myeloma (the ICON study): a multicentre, single-arm, phase 2 trial
Charlotte L B M Korst, MDa ∙ Wouter Plattel, MD PhDb ∙ Elizabeth A de Kort, MD PhDc ∙ Febe Smits, MDa,d ∙ Alexandra J Croockewit, MD PhDc ∙ Mark-David Levin, MD PhDe ∙ et al.
https://www.thelancet.com/journals/lanhae/article/PIIS2352-3026(25)00298-4/abstract?dgcid=raven_jbs_etoc_feature_lanhae
Jan 2026
Volume 13Number 1e1-e54
https://www.thelancet.com/journals/lanhae/issue/vol13no1/PIIS2352-3026(25)X0013-2
Suscribirse a:
Enviar comentarios (Atom)


No hay comentarios:
Publicar un comentario